Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal. | Ther Adv Med Oncol | 2023 | 37389189 | PubTator, text mining | PubMed |
| Recent advances in developing degraders & inhibitors of lysine methyltransferases. | Curr Opin Chem Biol | 2023 | 37379717 | PubTator, text mining | PubMed |
| CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins. | Nucleic Acids Res | 2023 | 37378433 | PubTator, text mining | PubMed |
| Nanotechnology-Aided Advancement in Combating the Cancer Metastasis. | Pharmaceuticals (Basel) | 2023 | 37375846 | PubTator, text mining | PubMed |
| The CUL4B-based E3 ubiquitin ligase regulates mitosis and brain development by recruiting phospho-specific DCAFs. | EMBO J | 2023 | 37365982 | PubTator, text mining | PubMed |
| iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells. | iScience | 2023 | 37360684 | PubTator, text mining | PubMed |
| Target 2035 - an update on private sector contributions. | RSC Med Chem | 2023 | 37360399 | PubTator, text mining | PubMed |
| GATS tag system is compatible with biotin labelling methods for protein analysis. | Sci Rep | 2023 | 37353572 | PubTator, text mining | PubMed |
| Development of KEAP1-targeting PROTAC and its antioxidant properties: In vitro and in vivo. | Redox Biol | 2023 | 37348157 | PubTator, text mining | PubMed |
| Design and synthesis of a fluorescent probe to develop a fluorescence polarization assay for the E3 ligase FEM1C. | Bioorg Med Chem | 2023 | 37339537 | PubTator, text mining | PubMed |
| RIPK2: a promising target for cancer treatment. | Front Pharmacol | 2023 | 37324457 | PubTator, text mining | PubMed |
| Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders. | ACS Omega | 2023 | 37323408 | PubTator, text mining | PubMed |
| A multi-centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait. | BMC Cancer | 2023 | 37316784 | PubTator, text mining | PubMed |
| Mitotic tethering enables inheritance of shattered micronuclear chromosomes. | Nature | 2023 | 37316668 | PubTator, text mining | PubMed |
| Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers. | Onco Targets Ther | 2023 | 37309471 | PubTator, text mining | PubMed |
| Narrow funnel-like interaction energy distribution is an indicator of specific protein interaction partner. | iScience | 2023 | 37305691 | PubTator, text mining | PubMed |
| Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy? | Front Mol Neurosci | 2023 | 37305556 | PubTator, text mining | PubMed |
| An Overview of Targeted Therapies in Acute Myeloid Leukemia. | Hemasphere | 2023 | 37304938 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals the prognostic and immunologic roles of cereblon and its significance for PROTAC design. | Heliyon | 2023 | 37303568 | PubTator, text mining | PubMed |
| Design, Synthesis and Biological Evaluation of α-Synuclein Proteolysis-Targeting Chimeras. | Molecules | 2023 | 37298935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=34